Enterprise Pharmacy Forward

Oncology Pharmacy

Centralizing oncology drug authorizations: Geisinger’s partnership with OncoHealth drives efficiency and savings

Centralizing oncology drug authorizations: Geisinger’s partnership with OncoHealth drives efficiency and savings

Authors: Jessie Bitler and Kimberly Clark OncoHealth began overseeing Geisinger Health Plan’s Medicare Part B oncology drug prior authorizations for non-Geisinger providers on May 23, 2024. This initial implementation represented a strategic advancement in optimizing the approval process for oncology therapies, yielding appropriate, efficient, cost-effective care for

One year of CAR-T therapy: Advancing personalized cancer treatment at Geisinger

Authors: Lori Stopper, RPh, PharmD, Kayla Aufiero, RPh, PharmD Geisinger Medical Center in Danville and the Geisinger Cancer Institute have successfully completed the first year of chimeric antigen receptor T-cell (CAR-T) therapy infusions, treating 12 patients with the goal of achieving long-term remission — or even a potential

Geisinger Cancer Center Dickson City opens, expanding access to advanced oncology care

Authors: Justine Zuk and Ralph Ferraro On June 23, the new Geisinger Cancer Center Dickson City welcomed its first patient, marking a major milestone in the expansion of advanced cancer care across northeastern Pennsylvania. This momentous occasion reflects the culmination of months of tireless dedication and teamwork. Every member of

Transforming cancer care: Expanding home infusion access for blinatumomab therapy

Authors: Benjamin Andrick, Ron Zsido and Nichole Varela-Gonzalez Over the past year, the health system continued to advance cancer care delivery by expanding access to high-acuity therapies in the home setting. Among the most impactful initiatives was the development and implementation of a coordinated home infusion program for